These results indicate marked liver pathogenesis with consequently decreased levels of circulating IGF1, caused by hepatic SMN deficiency at the advanced-disease stages in this adult-onset SMA context. This evidence concerns the gene SMN2 and hyperinsulinemic hypoglycemia, familial, 4.